Amylyx Pharmaceuticals Insider Sold Shares Worth $830,904, According to a Recent SEC Filing
MT newswire2026/10/07 20:1404:14 PM EDT, 10/07/2026 (MT Newswires) -- George M Milne Jr, Director, on October 05, 2026, sold 30,000 shares in Amylyx Pharmaceuticals (AMLX) for $830,904. Following the Form 4 filing with the SEC, Milne has control over a total of 782,881 common shares of the company, with 782,881 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1658551/000119312526416950/xslF345X05/ownership.xml
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
